Concept information
Preferred term
Bromodeoxyuridine
Type
-
mesh:Descriptor
Definition
- A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.
Broader concept
Entry terms
- 59-14-3 (Bromodeoxyuridine)
- 5-Bromo-2'-deoxyuridine
- 5-Bromodeoxyuridine
- BrdU
- Bromouracil Deoxyriboside
- Broxuridine
- BUdR
- G34N38R2N1
- Uridine, 5-bromo-2'-deoxy-
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
5-Bromo-2'-désoxyuridine
-
59-14-3 (Bromodeoxyuridine)
-
BrdU
-
Bromodésoxyuridine
-
G34N38R2N1
-
Uridine, 5-bromo-2'-deoxy-
URI
http://data.loterre.fr/ark:/67375/JVR-JSSRTQMN-X
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}